CVS expands drug delivery across nation

CVS Pharmacy is expanding its delivery service, CarePass, nationwide at participating pharmacy locations, the company announced.

The program, which offers prescription drug delivery for free on select drugs and other benefits for a monthly membership fee, was originally a pilot project in select markets, where CVS found broad appeal from customers. Of its CarePass audience, 20% are millennials, CVS stated.

"Initial customer response has exceeded our expectations with members utilizing the program's full benefits and becoming more engaged across all of our digital offerings,” Kevin Hourican, executive vice president, CVS Health and President, CVS Pharmacy, said in a statement.

Members of CarePass pay $5 per month, or $48 for an annual membership to receive delivery of prescription medications, access to a pharmacist helpline anytime, other special discounts on CVS Health brand items, and a monthly $10 promotional reward for in-store and online items. CarePass members also receive a free sports physical as part of their membership at their local MinuteClinic.

CVS also said it’s seeing a boost in customer purchases of about 15% to 20% from members who join the CarePass program.

The expansion of the program comes at a time when competitors from outside the industry are trying to stake a claim in the space. Amazon purchased online pharmacy PillPack last year as part of its venture into healthcare.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup